CVI Holdings’s BiondVax Pharmaceuticals Ltd. BVXVW Stock Holding History

CVI Holdings’s Portfolio BVXVW Stock Details BVXVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-72,800	Closed	-$189K	–	52
2019 Q4	$189K	Hold	72,800	–	–	0.27%	22
2019 Q3	$45K	Hold	72,800	–	–	0.1%	27
2019 Q2	$52K	Hold	72,800	–	–	0.06%	45
2019 Q1	$25K	Hold	72,800	–	–	0.02%	44
2018 Q4	$31K	Hold	72,800	–	–	0.07%	29
2018 Q3	$85K	Hold	72,800	–	–	0.14%	27
2018 Q2	$92K	Hold	72,800	–	–	0.11%	34
2018 Q1	$87K	Buy	+72,800	New	+$113K	0.12%	33

Other funds holding BVXVW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

CVI Holdings's BVXVW Position: Q1 2020 in Review

CVI Holdings sold out of BiondVax Pharmaceuticals Ltd. (BVXVW) in Q1 2020, closing a stake of 72,800 shares — an estimated $189K sold.

CVI Holdings first reported a position in BVXVW in Q1 2018 and held it in 8 quarters. The position peaked at $189K in Q4 2019. 2 funds tracked by Wall St. Rank hold BVXVW as of Q1 2020.

CVI Holdings reported no remaining BiondVax Pharmaceuticals Ltd. position as of Q1 2020 after selling out during the quarter.
CVI Holdings sold 72,800 BiondVax Pharmaceuticals Ltd. shares in Q1 2020, an estimated $189K.
CVI Holdings first reported a position in BiondVax Pharmaceuticals Ltd. in Q1 2018 and held it in 8 quarters.
CVI Holdings's BiondVax Pharmaceuticals Ltd. position peaked at $189K in Q4 2019.
2 funds tracked by Wall St. Rank held BiondVax Pharmaceuticals Ltd. as of Q1 2020.

Based on CVI Holdings's 13F filing for Q1 2020, filed 15 May 2020.